Dr. Zhao is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
593 Eddy St
Providence, RI 02903Phone+1 401-444-8524
Education & Training
- The Warren Alpert Medical School of Brown UniversitySurgical/GI pathology fellowship, 2017 - 2018
- Brown UniversityResidency, Pathology-Anatomic and Clinical, 2013 - 2017
- Brown UniversityChief Residency, Pathology-Anatomic and Clinical, 2015 - 2016
- Rush University Medical CenterPost-Doctoral Fellowship, 2010 - 2013
- Northwestern Memorial HospitalPost-Doctoral Fellowship, 2009 - 2010
- Rush University Medical CenterPost-Doctoral Fellowship, 2007 - 2009
- Rush University Medical CenterPhD, Pharmacology, • John E. Trufant Award for Excellence in Research (2007) • Paul E. Carson, M.D. Award for Excellence in Pharmacology (2007), 2003 - 2007
- Rush UniversityPh.D., Pharmacology, 2003 - 2007
- Fujian Medical UniversityMS, Gerontology, • Golden Prize of Medical Education Scholarship of the United Laboratories (2003), 2000 - 2003
- Fujian Medical UniversityM.S., Gerontology, 2000 - 2003
- Shanghai Medical UniversityClass of 1996
Certifications & Licensure
- CT State Medical License 2023 - 2025
- GA State Medical License 2023 - 2025
- MA State Medical License 2024 - 2025
- NC State Medical License 2023 - 2025
- NJ State Medical License 2024 - 2025
- NY State Medical License 2018 - 2025
- PA State Medical License 2016 - 2024
- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
- Join now to see all
Publications & Presentations
PubMed
- 135 citationsTNF-α knockout and minocycline treatment attenuates blood–brain barrier leakage in MPTP-treated miceChaohui Zhao, Zaodung Ling, Mary B. Newman, Ankush Bhatia, Paul M. Carvey
Neurobiology of Disease. 2007-04-01 - 10 citationsLipocalin-type prostaglandin D2 synthase deletion induces dyslipidemia and non-alcoholic fatty liver disease.Sunil Kumar, Ankita Srivastava, Thomas Palaia, Christopher J. Hall, Jenny J. Lee
Prostaglandins & Other Lipid Mediators. 2020-03-04 - 51 citationsPathological findings in the postmortem liver of patients with coronavirus disease 2019 (COVID-19)Chaohui Lisa Zhao, Amy Rapkiewicz, Mona Maghsoodi-Deerwester, Mala Gupta, Wenqing Cao
Human Pathology. 2021-03-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: